SCHEMBL25515345

SCHEMBL25515345

CN[C@H](C)Cc1ccc2ccccn12

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.46
SLC18A2 Q05940 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
SLC6A4 P31645 3/20 0.34
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
GFER P55789 1/20 0.33
ALDH1A1 P00352 2/20 0.31
KDM4E B2RXH2 1/20 0.31
CHEK1 O14757 1/20 0.31
MAPT P10636 1/20 0.31
LIMK1 P53667 1/20 0.31
MAPK14 Q16539 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
SLC6A2 P23975 1/20 0.30
SLC6A3 Q01959 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25509953 1.00 TAAR1 (0.46) TAAR1SLC18A2SIGMAR1SLC6A4CYP2D6
SCHEMBL25510168 0.88 TAAR1 (0.43) TAAR1SLC18A2SIGMAR1SLC6A4CYP2D6
SCHEMBL25510070 0.84 SIGMAR1 (0.49) SIGMAR1SLC6A4CYP2D6MAPT
SCHEMBL25510072 0.81 SLC6A4 (0.37) SLC6A4
SCHEMBL25515982 0.79 SLC6A4 (0.42) TAAR1SIGMAR1SLC6A4SLC6A2SLC6A3
SCHEMBL25175015 0.78
SCHEMBL25510071 0.73 HTR2A (0.36) SLC6A4ALDH1A1KDM4ECHEK1MAPT
SCHEMBL7169853 0.72 ALDH1A1 (0.37) ALDH1A1KDM4ECHEK1MAPTLIMK1
SCHEMBL25510170 0.72 SIGMAR1 (0.46) SIGMAR1SLC6A4MAPT
SCHEMBL14339186 0.71 KDM4E (0.33) ALDH1A1KDM4ECHEK1MAPTLIMK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081306-A1 INDOLIZINE COMPOUNDS FOR THE TREATMENT OF MENTAL DISORDERS OR MENTAL ENHANCEMENT TACTOGEN INC (US) 2023-05-11 WO disclosed